oxyPharma

Tirzepatide OXY-TIRZE (5 mg) OxyPharma

Name: Tirzepatide OXY-TIRZE (5 mg) OxyPharma
Brand: oxyPharma

0 customer reviews

Price on request

Tirzepatide 5 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 5 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising treatme

● Out of stock

SKU: tirzepatide-oxy-tirze-5-mg-oxypharma-default
Brand: oxyPharma
Category: Peptides

Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines the action of two incretin hormones in a single peptide. By stimulating insulin secretion after meals and suppressing glucagon secretion between meals, it supports both post-meal and fasting blood sugar stability while also acting on appetite centers to reduce hunger. This OxyPharma vial contains 5 mg of Tirzepatide, a practical strength for the early titration phase.

This dual mechanism gives Tirzepatide a stronger overall metabolic effect than single-pathway peptides, supporting significant, gradual weight loss alongside improved glycemic control and cardiovascular support.

Key Benefits

Dual GIP/GLP-1 action for stronger glycemic and appetite control than single-receptor peptides
Suppresses appetite and increases satiety, supporting gradual weight loss
Stabilizes blood glucose both after meals and between meals
Supports cardiovascular health markers relevant to metabolic patients
5 mg vial suits users starting out or working through early titration steps